Home › Neurologic Diseases
Neurologic Diseases clinical trials recruiting in the U.S.
56 studies for Neurologic Diseases are recruiting participants at sites across the United States.
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
Cities with the most studies
- Boston, MA10 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- Washington, DC7 studies
- Philadelphia, PA7 studies
- Dallas, TX7 studies
- Houston, TX7 studies
- San Diego, CA6 studies
- St. Louis, MO6 studies
- Austin, TX5 studies
- New York City, NY5 studies
- Los Angeles, CA5 studies
- Chicago, IL5 studies
- Cincinnati, OH5 studies
- San Antonio, TX4 studies
- West Palm Beach, FL4 studies
- Tampa, FL4 studies
- Durham, NC4 studies
- Arlington, VA4 studies
- Atlanta, GA4 studies
- Pittsburgh, PA4 studies
- Birmingham, AL4 studies
- Aurora, CO4 studies
- Scottsdale, AZ3 studies
- Naples, FL3 studies
- Phoenix, AZ3 studies
- Denver, CO3 studies
- Hollywood, FL3 studies
- Stamford, CT3 studies
- Memphis, TN3 studies
- Akron, OH3 studies
- Ann Arbor, MI3 studies
- Jacksonville, FL3 studies
- Lansing, MI3 studies
- Columbus, OH3 studies
- Staten Island, NY3 studies
- Seattle, WA3 studies
- Newark, NJ3 studies
By state
- Alabama5 studies
- Arizona5 studies
- California10 studies
- Colorado8 studies
- Connecticut4 studies
- Florida13 studies
- Georgia5 studies
- Illinois5 studies
- Kansas3 studies
- Maryland10 studies
- Massachusetts12 studies
- Michigan8 studies
- Minnesota3 studies
- Missouri7 studies
- New Jersey7 studies
- New York7 studies
- North Carolina7 studies
- Ohio8 studies
- Oregon3 studies
- Pennsylvania10 studies
- South Carolina4 studies
- Tennessee4 studies
- Texas13 studies
- Virginia5 studies
- Washington6 studies
Recently updated studies
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Nov 12, 2026 · NCT06887192Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology
RecruitingObservational studyHealthy volunteers welcome
Ages 3 to 99 · All sexes · Updated Nov 12, 2026 · NCT06203626Evaluation and Treatment of Neurosurgical Disorders
RecruitingObservational study
Ages 4 to 99 · All sexes · Updated Nov 10, 2026 · NCT00060541A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07098806Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
RecruitingObservational study
7 Months – 15 Months · All sexes · Updated Nov 5, 2026 · NCT06805695A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Nov 4, 2026 · NCT07589595A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Nov 3, 2026 · NCT07598708A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Oct 29, 2026 · NCT06297590Product Surveillance Registry
RecruitingObservational study
All ages · All sexes · Updated Oct 20, 2026 · NCT01524276A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06916806An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
RecruitingPhase 1/2
6 Months · All sexes · Updated Oct 19, 2026 · NCT05757141A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 15, 2026 · NCT07459647Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Recruiting
Ages 50 and older · All sexes · Updated Oct 15, 2026 · NCT06993142Ear-Seizure Detection (EarSD) Study
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06598189NightWare and Cardiovascular Health in Veterans With PTSD
RecruitingHealthy volunteers welcome
Ages 22 to 88 · All sexes · Updated Oct 8, 2026 · NCT06419959Pediatric Epilepsy
Recruiting
Ages 3 to 25 · All sexes · Updated Oct 6, 2026 · NCT07350551A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study)
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 1, 2026 · NCT07704840The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
RecruitingObservational studyHealthy volunteers welcome
6 Weeks · All sexes · Updated Sep 29, 2026 · NCT00271622HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Top-Down Attentional Control of Visual-Processing
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Aug 24, 2026 · NCT01087281Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
Recruiting
Ages 3 to 21 · All sexes · Updated Aug 19, 2026 · NCT05527652Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
Recruiting
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07218133Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Recruiting
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07759115Ask Questions About Clinical Trials
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07343297From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.